1,630 Shares in UnitedHealth Group Incorporated (NYSE:UNH) Bought by 3Chopt Investment Partners LLC

3Chopt Investment Partners LLC bought a new position in UnitedHealth Group Incorporated (NYSE:UNH) in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor bought 1,630 shares of the healthcare conglomerate’s stock, valued at approximately $830,000.

Several other hedge funds and other institutional investors have also made changes to their positions in the stock. Granite Bay Wealth Management LLC bought a new position in shares of UnitedHealth Group during the 2nd quarter valued at about $4,470,000. Ted Buchan & Co purchased a new stake in shares of UnitedHealth Group during the 2nd quarter valued at about $1,748,000. Advisory Alpha LLC raised its position in shares of UnitedHealth Group by 7.8% during the 2nd quarter. Advisory Alpha LLC now owns 4,415 shares of the healthcare conglomerate’s stock valued at $2,249,000 after buying an additional 320 shares in the last quarter. Truist Financial Corp raised its position in shares of UnitedHealth Group by 46.7% during the 2nd quarter. Truist Financial Corp now owns 898,406 shares of the healthcare conglomerate’s stock valued at $457,522,000 after buying an additional 286,122 shares in the last quarter. Finally, Pathway Financial Advisers LLC raised its position in shares of UnitedHealth Group by 3.5% during the 2nd quarter. Pathway Financial Advisers LLC now owns 6,718 shares of the healthcare conglomerate’s stock valued at $3,372,000 after buying an additional 230 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

Insider Buying and Selling

In related news, EVP Erin Mcsweeney sold 1,500 shares of the company’s stock in a transaction dated Thursday, July 18th. The shares were sold at an average price of $579.03, for a total transaction of $868,545.00. Following the completion of the sale, the executive vice president now owns 7,785 shares of the company’s stock, valued at approximately $4,507,748.55. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. In other news, CAO Thomas E. Roos sold 2,851 shares of the stock in a transaction that occurred on Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total value of $1,624,727.88. Following the completion of the sale, the chief accounting officer now owns 29,501 shares of the company’s stock, valued at approximately $16,812,029.88. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, EVP Erin Mcsweeney sold 1,500 shares of the stock in a transaction that occurred on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total transaction of $868,545.00. Following the completion of the sale, the executive vice president now directly owns 7,785 shares of the company’s stock, valued at approximately $4,507,748.55. The disclosure for this sale can be found here. Insiders own 0.33% of the company’s stock.

UnitedHealth Group Stock Up 0.5 %

UNH opened at $584.68 on Tuesday. The company has a fifty day moving average of $579.93 and a two-hundred day moving average of $525.06. The stock has a market capitalization of $539.91 billion, a price-to-earnings ratio of 35.74, a PEG ratio of 1.62 and a beta of 0.58. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $607.94. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.88 and a current ratio of 0.88.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share for the quarter, topping analysts’ consensus estimates of $6.66 by $0.14. The business had revenue of $98.86 billion during the quarter, compared to the consensus estimate of $98.73 billion. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The company’s revenue was up 6.4% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $6.14 earnings per share. On average, research analysts expect that UnitedHealth Group Incorporated will post 27.69 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 24th. Investors of record on Monday, September 16th were given a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, September 16th. This represents a $8.40 annualized dividend and a dividend yield of 1.44%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 51.34%.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on UNH shares. UBS Group increased their price objective on shares of UnitedHealth Group from $640.00 to $680.00 and gave the stock a “buy” rating in a research report on Thursday, July 18th. Robert W. Baird increased their price objective on shares of UnitedHealth Group from $597.00 to $640.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 17th. TD Cowen raised their target price on shares of UnitedHealth Group from $546.00 to $601.00 and gave the stock a “buy” rating in a research report on Wednesday, July 17th. Royal Bank of Canada raised their target price on shares of UnitedHealth Group from $555.00 to $615.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 17th. Finally, Barclays raised their target price on shares of UnitedHealth Group from $560.00 to $604.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 17th. Two equities research analysts have rated the stock with a hold rating, eighteen have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and a consensus price target of $614.17.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.